Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Souvenaid

- PMLiVE

FDA expecting boom in cell and gene therapies

Pledges clampdown on developers working outside regulations

- PMLiVE

China approves Ironwood Pharma’s IBS treatment

Coincides with AZ's Mark Mallon taking over as CEO

- PMLiVE

Industry pleads for compromise after Brexit defeat

Prime Minister is more boxed in than ever, but unlikely to be toppled

The UK’s new five-year pricing agreement

Pharma has agreed to capped growth again - in exchange for uptake promises

Lucid kick-starts 2019 with spellbinding new additions to its writing and account teams

It’s been a busy start to 2019, with Lucid Group bolstering its account and medical writing teams with three new additions.Elaine Downey joins Vivid as a Senior Account Manager; she...

Lucid Group Communications Limited

- PMLiVE

New hires at Nanoform, Leo Pharma and Calliditas

The latest movers in pharma and biotech

Lucid Group prepare for a transformative year with the appointment of a new Director of Corporate Development

Lucid Group is setting itself up for another stellar year with a new appointment to their senior leadership team. Rob Apollo has joined Lucid on a permanent basis as Director...

Lucid Group Communications Limited

- PMLiVE

Crunch time as Brexit deal faces ‘meaningful vote’

Rejecting the deal would either result in a no deal or no Brexit, warns May

- PMLiVE

EU approval for Opdivo combo in renal cell cancer

BMS one step ahead of rivals

- PMLiVE

NHS tech leader departs for digital GP service

Hands baton over to Health Innovation Network chief

- PMLiVE

FDA moves into crisis mode as shutdown drags on

New drug appraisals already being affected

Launch excellence: beyond the six-month mantra

While the first six months are important, the prior 36 months are even more so.

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links